Reference:
1. Tandon VR. Meformin therapy: Benefits beyond glycemic control. Int J Diab Dev Ctries 2007; 27(1): 1-4.
2. Panicker GK, Karnad DR, Salvi V, Kothari S. Cardiovascular risk of oral antidiabetic drug: current evidene and regulatory requirements for new drugs. J Assoc Physicians India 2012; 60: 56-61
3. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 (suppl 1): S11-S66.
Keywords:
-